Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 22;16(12):1504.
doi: 10.3390/pharmaceutics16121504.

Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis

Affiliations
Review

Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis

Wafa Ali Batarfi et al. Pharmaceutics. .

Abstract

Inflammation and apoptosis are interrelated biological processes that have a significant impact on the advancement and growth of certain chronic diseases, such as cardiovascular problems, neurological conditions, and osteoarthritis. Recent research has emphasized that focusing on these mechanisms could result in novel therapeutic approaches that aim to decrease the severity of diseases and enhance patient outcomes. Hydroxytyrosol (HT), which is well-known for its ability to prevent oxidation, has been identified as a possible candidate for regulating both inflammation and apoptosis. In this review, we will highlight the multifaceted benefits of HT as a therapeutic agent in mitigating inflammation, apoptosis, and associated conditions. This review provides a comprehensive overview of the latest in vitro and in vivo research on the anti-inflammatory and antiapoptotic effects of HT and the mechanisms by which it works. Based on these studies, it is strongly advised to use HT as a bioactive ingredient in pharmaceutical products intended for mitigating inflammation, as well as those with apoptosis applications.

Keywords: apoptosis; hydroxytyrosol; inflammation; natural products.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Natural sources, chemical structure, and health benefits of HT. Created with BioRender.com. (https://www.biorender.com) (accessed on 26 August 2024).
Figure 2
Figure 2
Bioavailability of HT inside the human body. Created with BioRender.com. https://app.biorender.com (accessed on 2 October 2024).
Figure 3
Figure 3
Anti-inflammatory effect of HT on NF-kB signaling pathway. Created with BioRender.com. https://app.biorender.com (accessed on 28 August 2024).
Figure 4
Figure 4
Extrinsic and intrinsic apoptosis pathway. Created with BioRender.com. (https://app.biorender.com (accessed on 28 August 2024).
Figure 5
Figure 5
Antiapoptotic effect of HT on the extrinsic apoptotic pathway. Created with BioRender.com. https://app.biorender.com (accessed on 30 August 2024).

Similar articles

Cited by

References

    1. Ikwegbue P.C., Masamba P., Oyinloye B.E., Kappo A.P. Roles of heat shock proteins in apoptosis, oxidative stress, human inflammatory diseases, and cancer. Pharmaceuticals. 2017;11:2. doi: 10.3390/ph11010002. - DOI - PMC - PubMed
    1. Kunnumakkara A.B., Sailo B.L., Banik K., Harsha C., Prasad S., Gupta S.C., Bharti A.C., Aggarwal B.B. Chronic diseases, inflammation, and spices: How are they linked? J. Transl. Med. 2018;16:14. doi: 10.1186/s12967-018-1381-2. - DOI - PMC - PubMed
    1. Leuti A., Fazio D., Fava M., Piccoli A., Oddi S., Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv. Drug Deliv. Rev. 2020;159:133–169. doi: 10.1016/j.addr.2020.06.028. - DOI - PubMed
    1. Tsoupras A., Lordan R., Zabetakis I. Inflammation, not cholesterol, is a cause of chronic disease. Nutrients. 2018;10:604. doi: 10.3390/nu10050604. - DOI - PMC - PubMed
    1. Chung H.Y., Kim D.H., Lee E.K., Chung K.W., Chung S., Lee B., Seo A.Y., Chung J.H., Jung Y.S., Im E. Redefining chronic inflammation in aging and age-related diseases: Proposal of the senoinflammation concept. Aging Dis. 2019;10:367–382. doi: 10.14336/AD.2018.0324. - DOI - PMC - PubMed

LinkOut - more resources